ニュース
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
A new study found that over half of people who had a transient ischemic attack (also called ministroke) had fatigue lasting a ...
Measles meets the official definition of epidemic as experts speculate that the virus has established itself permanently in ...
Diets high in junk food may increase the risk of symptoms tied to early Parkinson’s disease, like depression and impaired ...
Methylene blue is FDA-approved to treat a rare blood disorder, but influencers are touting it as a brain and longevity ...
The U.S. Food and Drug Administration approved the Teal Wand as the first alternative to in-office Pap smears, which many ...
When an ovarian cyst ruptures, you can expect anything from mild discomfort to severe pain. Know the symptoms and what to do ...
Learn the importance of cardiovascular fitness, which aerobic exercises build it, and how it’s measured. Read on for expert ...
Gastritis — when the stomach lining becomes inflamed — often stems from factors like bacterial infections including Helicobacter pylori, long-term use of nonsteroidal anti-inflammatory drugs ...
In a new study, the semaglutide weight loss drug helped 2 out of 3 people with a life-threatening condition linked to fat accumulation in the liver. In a late-stage clinical trial, Wegovy ...
“Black and Latina women may face higher cumulative exposure, particularly from leave-on products like hair relaxers that are ...
Girls should see a gynecologist for the first time between ages 13 and 15. But earlier visits may be necessary for concerns ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する